Source: http://feedproxy.google.com/~r/mnt/healthnews/~3/9oLTEsz7qUc/252765.php
Thursday, 15 November 2012
Brain Tumors Shrunk In Children With Tuberous Sclerosis Complex
A drug originally developed to prevent the rejection of transplanted organs has now been shown to dramatically reduce a particular kind of brain tumor in patients with tuberous sclerosis complex (TSC) -- a genetic disease that causes tumors to grow on vital organs. The study, published online in The Lancet, is the latest to show the effectiveness of everolimus in slowing the cell growth that is overactive in patients with TSC...
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment